Drreddys Laboratories | RDY - El Costo De Ventas





El Costo De Ventas Cambio Fecha
ANI Pharmaceuticals USD 119.8M 5.3M 2026-06
Aurora Cannabis CAD 8.22M 80.38M 2026-03
Bayer EUR 4.54B 692M 2026-06
Canopy Growth CAD 62.98M 9.91M 2026-03
Cipla INR 29.71B 3.4B 2026-06
Corcept Therapeutics USD 4.06M 1.18M 2026-06
Drreddys Laboratories INR 32.13B 8.34B 2026-03
GlaxoSmithKline GBP 2.07B 192M 2026-06
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lonza CHF 2.28B 189M 2025-06
Novartis USD 3.71B 251M 2026-06
Pacira USD 58.49M 7.75M 2026-06
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 135.22M 5.54M 2026-06
Richter Gedeon HUF 72.45B 1.13B 2026-03
Sun Pharmaceuticals INR 37.02B 9.01B 2026-06
Supernus Pharmaceuticals USD 59M 9.97M 2026-06
Teva Pharmaceutical Industries USD 1.98B 30M 2026-06